Resources with keywords: vaccination
Hause AM, Marquez P, Zhang B, et al.
Wong MK, Brooks DJ, Ikejezie J, et al.
COVID-19–associated mortality among persons aged ≥60 years exceeded 80% of total COVID-19 mortality in 2020 and 2021 across all income groups.
Key points follow. Mass vaccination is not required nor recommended for monkeypox at this time; Primary preventive (pre-exposure) vaccination (PPV) is recommended for individuals at high-risk of exposure.
Hause AM, Marquez P, Zhang B, et al.
Early safety findings from v-safe and the Vaccine Adverse Event Reporting System for bivalent booster doses administered to persons aged ≥12 years during the first 7 weeks of vaccine availability are similar to those previously described for monovalent vaccine booster vaccines.
Kuodi, P., Gorelik, Y., Zayyad, H. et al.
Vaccination with at least two doses of COVID-19 vaccine was associated with a substantial decrease in reporting the most common post-acute COVID-19 symptoms, bringing it back to baseline. Our results suggest that, in addition to reducing the risk of acute illness, COVID-19 vaccination may have a protective effect against long COVID.
The interview discusses modes transmission, communication, and vaccination.
Susan McLellan, MD, MPH
